|
|
Article: Biomagnetics (BMGP) in Genetic Engineering & Biotechnology News for Chinese Biotechnology Initiative.
- Article from:
- Business Wire
- Article date:
- September 17, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ORANGEVALE, Calif. -- Biomagnetics Diagnostics Corp. (OTC:BMGP), announces today that the company has recently been profiled in international stem cell, genetic engineering and biotechnology publications for their Chinese Biotechnology Initiative and a potential Austrian joint venture involving utilization of BMGP's technology and Gene Therapeutic Vector Development.
Clayton Hardman, CEO of BMGP also announced that the company is continuing to review the proposal from an Austrian based genetic engineering company and an independent research foundation. The proposal will grant us access to their patented viral painting technology, scientists, and laboratories to ...